Bilastine impurity 18, identified by its CAS number 1638785-19-9, is a chemical compound that is recognized as an impurity associated with the antihistamine bilastine. While specific characteristics such as its molecular structure, physical properties, and reactivity may not be widely documented, impurities in pharmaceutical compounds typically arise during the synthesis or storage processes and can affect the purity and efficacy of the final product. Generally, impurities may exhibit different solubility, stability, and biological activity compared to the parent compound. The presence of impurities like Bilastine impurity 18 is crucial to monitor in pharmaceutical formulations to ensure safety and compliance with regulatory standards. Analytical techniques such as high-performance liquid chromatography (HPLC) and mass spectrometry are often employed to identify and quantify such impurities. Understanding the characteristics of impurities is essential for quality control in drug development and manufacturing, as they can influence the pharmacokinetics and pharmacodynamics of the active pharmaceutical ingredient.

Bilastine impurity 18

1638785-19-9: Bilastine impurity 18, identified by its CAS number 1638785-19-9, is a chemical compound that is recognized as an impurity associated with the antihistamine bilastine. While specific characteristics such as its molecular structure, physical properties, and reactivity may not be widely documented, impurities in pharmaceutical compounds typically arise during the synthesis or storage processes and can affect the purity and efficacy of the final product. Generally, impurities may exhibit different solubility, stability, and biological activity compared to the parent compound. The presence of impurities like Bilastine impurity 18 is crucial to monitor in pharmaceutical formulations to ensure safety and compliance with regulatory standards. Analytical techniques such as high-performance liquid chromatography (HPLC) and mass spectrometry are often employed to identify and quantify such impurities. Understanding the characteristics of impurities is essential for quality control in drug development and manufacturing, as they can influence the pharmacokinetics and pharmacodynamics of the active pharmaceutical ingredient.

CAS 1638785-19-9

Bilastine impurity 18

Bilastine Impurity 13

Ref: 4Z-B-1718

Methyl 2-(4-(2-Chloroacetyl)phenyl)-2-methylpropanoate

Ref: TR-M346725

Bilastine Impurity 4

Ref: ST-EA-CP-B13011